Target intelligence / Profile preview

Ribosomal protein L32 pseudogene 16 (RPL32P16)

Target
RPL32P16
Molecular classification
Other (pseudogene)
01

Overview

**Ribosomal protein L32 pseudogene 16 (RPL32P16)** is a processed pseudogene belonging to the ribosomal protein L32 (RPL32) gene family. Pseudogenes such as RPL32P16 are sequences similar to their functional homologs but are generally not transcribed or translated into functional proteins. Most RPL32-related pseudogenes do not encode active proteins and do not have known molecular or disease associations. All available evidence indicates that RPL32P16 is noncoding and nonfunctional, and it is not considered a therapeutic target[1][3][7].\n\n**Notes:** \n- There are several pseudogenes in the RPL32 family, but only rare members (e.g., RPL32P3 in glioma biology[6]) have putative noncoding RNA regulatory roles, and these do *not* apply to RPL32P16 based on current published data.\n- All listings and major gene databases (GeneCards, Ensembl, OMIM, PubMed) confirm that RPL32P16 is annotated as a pseudogene and not as a protein-coding gene or target[1][3].

Other names
Ribosomal protein L32 pseudogene 16RPL32P16
02

Mechanism of action

None

03

Biological functions

None established for RPL32P16Parental gene (RPL32) involved in protein synthesis as a component of ribosome
04

Disease associations

None established for RPL32P16Parental gene (RPL32) associated with certain syndromes and developmental pathways, but not this pseudogene

Beyond the preview

Go deeper on Ribosomal protein L32 pseudogene 16 (RPL32P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L32 pseudogene 16 (RPL32P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call